Health and Fitness Health and Fitness
Mon, January 19, 2009
[ Mon, Jan 19th 2009 ] - Market Wire
FONAR Corporation : Largest Radiology Group in Ne .. k Purchases Two FONAR UPRIGHT Multi-Position MRIs
[ Mon, Jan 19th 2009 ] - Market Wire
UnitedHealth Group and United Health Foundation S .. s Day of Service Through Coalition to Fight Cardi
[ Mon, Jan 19th 2009 ] - Market Wire
Quidel Launches rsvtesting.com; Web Site Delivers .. Information on Respiratory Syncytial Virus (RSV)
Fri, January 16, 2009
[ Fri, Jan 16th 2009 ] - Market Wire
Myriad Genetics: Myriad Genetics Announces Second .. ter Fiscal 2009 Financial Results Conference Call
[ Fri, Jan 16th 2009 ] - Market Wire
Advaxis Files 8-K on European Patent Appeal
[ Fri, Jan 16th 2009 ] - Market Wire
Addenbrooke?s Hospital to Install Second TomoTherapy® HiArt® Treatment System
[ Fri, Jan 16th 2009 ] - Market Wire
Proton Laboratories Inc.: Proton Laboratories Introduces Its Proprietary Cooling Tower Process
[ Fri, Jan 16th 2009 ] - Market Wire
Advanced Medical Optics Receives FDA Approval for TECNIS® Multifocal Intraocular Lens
[ Fri, Jan 16th 2009 ] - Market Wire
Gilead Sciences to Release Fourth Quarter and Yea .. 08 Financial Results on Tuesday, January 27, 2009
[ Fri, Jan 16th 2009 ] - Market Wire
Coventry Health Care to Release Fourth Quarter 2008 Financial Results
[ Fri, Jan 16th 2009 ] - Market Wire
Proteonomix, Inc: Proteonomix, Inc. (PROT) Announ .. Appointment of Steven Byle to Its Board of Direct
[ Fri, Jan 16th 2009 ] - Market Wire
Healthways to Issue Financial Results for the Fou .. 2008 and Financial Guidance for 2009 after Market
[ Fri, Jan 16th 2009 ] - Market Wire
NeuroMetrix Launches emginnovation.com to Promote .. and Engage Specialists in Shaping the Future of N
[ Fri, Jan 16th 2009 ] - Market Wire
Magellan Health Services Announces Fourth Quarter .. ar 2008 Earnings Release Date and Conference Call
[ Fri, Jan 16th 2009 ] - Market Wire
Harte Gold Corp.: Dissident Proxy Circular Mailed .. areholders Meeting Shareholders of Harte Gold Cor
[ Fri, Jan 16th 2009 ] - Market Wire
Bristol-Myers Squibb To Announce Results For The .. ourth Quarter And Full Year Of 2008 On January 27
[ Fri, Jan 16th 2009 ] - Market Wire
Tenet Reaches Agreement with Blue Shield of California
[ Fri, Jan 16th 2009 ] - Market Wire
RTI Biologics Announces 2008 Unaudited Revenues, Estimates 2009 Revenues
[ Fri, Jan 16th 2009 ] - Market Wire
Inhibiton Therapeutics Updates Acquisition of Hydrogen Generating Alternative Energy Company
[ Fri, Jan 16th 2009 ] - Market Wire
AngioDynamics to Sponsor Symposium on First Human Clinical Experience with IRE Technology
Thu, January 15, 2009
[ Thu, Jan 15th 2009 ] - Market Wire
Cobalis Corp Gets Federal Court Approval to Launch Its Flagship Anti-Allergy Product PreHistin"
[ Thu, Jan 15th 2009 ] - Market Wire
Toxin Alert Inc.: Toxin Alert Completes Private Placement, Files Past Due Reports
[ Thu, Jan 15th 2009 ] - Market Wire
PerkinElmer India Pvt. Ltd. Receives Frost & Sull .. al Instruments Market Growth Excellence Award for
[ Thu, Jan 15th 2009 ] - Market Wire
Curis Announces Genentech?s Expected Initiation o .. dvanced Basal Cell Carcinoma with Hedgehog Pathwa
[ Thu, Jan 15th 2009 ] - Market Wire
PPD Announces Fourth Quarter and Full-Year 2008 Earnings Release, Webcast and Conference Call
[ Thu, Jan 15th 2009 ] - Market Wire
St. Jude Medical Announces Publication of 20-year .. bility in Aortic and Mitral Stented Tissue Valves
[ Thu, Jan 15th 2009 ] - Market Wire
Centene Corporation Schedules 2008 Fourth Quarter and Year-End Financial Results Conference Call
[ Thu, Jan 15th 2009 ] - Market Wire
USANA Supplement CoQuinone 30 Receives Approval by ConsumerLab.com
[ Thu, Jan 15th 2009 ] - Market Wire
Monogram Announces Record Revenue for 2008, Guida .. 9 and Plan for Achieving Sustainable Positive Cas
[ Thu, Jan 15th 2009 ] - Market Wire
Schaeffer's Street Stories: Eli Lilly & Co. Finally Settles Zyprexa Lawsuit

Schaeffer's Street Stories: Eli Lilly & Co. Finally Settles Zyprexa Lawsuit


Published on 2009-01-15 11:42:41, Last Modified on 2009-01-15 11:43:01 - Market Wire
  Print publication without navigation


CINCINNATI--([ BUSINESS WIRE ])--Investors in Eli Lilly & Co. (NYSE: LLY) may be finally sighing with relief as the lawsuit against the company regarding its antipsychotic drug Zyprexa has drawn to a close, though the news isn't great. The pharmaceutical giant has agreed to pay $1.42 billion, and pleaded guilty to a criminal charge in a long-awaited settlement with federal prosecutors who accused Lilly of illegally marketing Zyprexa.

Eli Lilly will pay $615 million to settle a criminal investigation and nearly $800 million to resolve civil investigations related to Zyprexa - $438 million to the federal government and $362 million available for settlements with states.

To continue reading this article, click here: [ http://www.schaeffersresearch.com/commentary/content/eli+lilly+co+finally+settles+zyprexa+lawsuit/observations.aspx?click=home&ID=90544 ]

Contributing Sources